Article info

Download PDFPDF

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients
  1. Correspondence to:
    Dr P Bekker Jeppesen
    Department of Medicine CA-2121, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; Bekkerdadlnet.dk
View Full Text

Citation

Jeppesen PB, Sanguinetti EL, Buchman A, et al
Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

Publication history

  • Accepted March 31, 2005
  • Revised February 10, 2005
  • First published August 11, 2005.
Online issue publication 
August 11, 2005
  • Competing interests: EL Sanguinetti and J Gregory are employees of NPS Pharmaceuticals Inc. PB Jeppesen, A Buchman, L Howard, T R Ziegler, K A Tappenden, J Holst, and P B Mortensen have served as consultants and received research support from NPS Pharmaceuticals Inc. J S Scolapio has no competing interests.

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.